본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Proteogenix

[Proteogenix] Pertuzumab Biosimilar – Anti-ERBB2, EGFR2, CD340 mAb – Research Grade

Cat-No. PX-TA1058


Proteogenix는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.




제품 설명 


Pertuzumab Biosimilar – Anti-ERBB2, EGFR2, CD340 mAb – Research Grade

  



제품 번호

 

PX-TA1058

 



제품 특징


Product namePertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade
SourceCAS 380610-27-5
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsPertuzumab,OMNITARG,rhuMAB 2C4,ERBB2, EGFR2, CD340,anti-ERBB2, EGFR2, CD340
ReferencePX-TA1058
NoteFor research use only. Not suitable for human use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody


Description of Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade

General information on Anti-ERBB2/EGFR2/CD340(Homo sapiens) (Pertuzumab) Monoclonal Antibody

Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (subdomain II) of human epidermal growth factor receptor 2 protein (HER2). It was first used with docetaxel and another HER2-targeting monoclonal antibody trastuzumab to treat metastatic HER2-positive breast cancer. Since then, its indications have been expanded to be used as both neoadjuvant therapy and adjuvant therapy for the treatment of HER2-positive breast cancer with a high risk of recurrence.




QC & Validation Data


Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb binds to Human CD340/ERBB2/HER2 in indirect ELISA Assay

Immobilized CD340 Recombinant Protein (cat. No. PX-P4121) at 0.5µg/mL (100µL/well) can bind Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb (cat. No. PX-TA1058) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 9.566M.

SDS-PAGE for Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb

Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.




Publications


  • Rocha Tapia A, Abgottspon F, Nilvebrant J, Nygren P-Å, Duclos Ivetich S, Bello Hernandez AJ, et al. Site-directed Conjugation of Single-Stranded DNA to Affinity Proteins: Quantifying the Importance of Conjugation Strategy. ChemRxiv. 2023; doi:10.26434/chemrxiv-2023-hxx06




ProteoGenix의 모든 제품들을 만나보세요!

 

Proteogenix - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"